Matches in Nanopublications for { ?s ?p "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP199639.RAYbdOXU8YLi5QKDDnP_f439F9zGRi6a71oyFDzV5TxwQ130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP199639.RAYbdOXU8YLi5QKDDnP_f439F9zGRi6a71oyFDzV5TxwQ130_provenance.
- NP757643.RAZ01edOmCdUoorFjNkSE5nNfjgm6l_O9oJIsZlSeFjVU130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757643.RAZ01edOmCdUoorFjNkSE5nNfjgm6l_O9oJIsZlSeFjVU130_provenance.
- assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP237072.RA_z7TQiEJYJK2Mx4vPR1BdrhSe0OAub_nZpbLhT-t8o4130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237072.RA_z7TQiEJYJK2Mx4vPR1BdrhSe0OAub_nZpbLhT-t8o4130_provenance.
- assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP438034.RAYpQLM6yLMIZALoMQpSEdzhvRu1Ac3AY1oUrt-QuXWGE130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438034.RAYpQLM6yLMIZALoMQpSEdzhvRu1Ac3AY1oUrt-QuXWGE130_provenance.
- NP438168.RAar2mfPcxPdlTS6KiTofTFZ5ppPWsIOhOf-K4S9b2T4w130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438168.RAar2mfPcxPdlTS6KiTofTFZ5ppPWsIOhOf-K4S9b2T4w130_provenance.
- NP439531.RATJXNm6JdpabyEUGPKGCzM-vBti284KJ7xDQO-8KrxZ4130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439531.RATJXNm6JdpabyEUGPKGCzM-vBti284KJ7xDQO-8KrxZ4130_provenance.
- NP581301.RAENw8CxEN8Jv2qG_zfnOJQJcoR5GOxNXpZFGzO8i_8o4130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581301.RAENw8CxEN8Jv2qG_zfnOJQJcoR5GOxNXpZFGzO8i_8o4130_provenance.
- NP365178.RAlcq4KAMku96LqqFiowxlyrRTuUTqW3SeByZSwTdn-xA130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365178.RAlcq4KAMku96LqqFiowxlyrRTuUTqW3SeByZSwTdn-xA130_provenance.
- NP439605.RA0FM3zbJNoheuZ754i5mNFHl1R64z6dr2stl8kr9zxSQ130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439605.RA0FM3zbJNoheuZ754i5mNFHl1R64z6dr2stl8kr9zxSQ130_provenance.
- NP365175.RAONW9S9Hb_T5AHdpxC58PlGsxqNzhd5rkdt6GNaxMYTQ130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365175.RAONW9S9Hb_T5AHdpxC58PlGsxqNzhd5rkdt6GNaxMYTQ130_provenance.
- NP365185.RAIpmp-hBBN9bKmqob6GCoL1k1blOIhFX_RD4BxOfgz8A130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365185.RAIpmp-hBBN9bKmqob6GCoL1k1blOIhFX_RD4BxOfgz8A130_provenance.
- NP365183.RA8X5drLHtdWVSuz-zTykfGo9PhFwVG024LdvCIkMCzAI130_assertion description "[The most remarkable risk was seen for the small cell carcinoma among subjects with the GSTP1*B/*B genotype and concurrent lack of the GSTM1 gene (OR = 6.9, 95% CI 1.6-30.2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365183.RA8X5drLHtdWVSuz-zTykfGo9PhFwVG024LdvCIkMCzAI130_provenance.